Pages that link to "Q66725167"
Jump to navigation
Jump to search
The following pages link to Kimiaki Utsugisawa (Q66725167):
Displaying 43 items.
- International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r (Q30276744) (← links)
- Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis (Q31024231) (← links)
- Early fast-acting treatment strategy against generalized myasthenia gravis (Q33834012) (← links)
- Quality of life in purely ocular myasthenia in Japan (Q33869796) (← links)
- Insights into the classification of myasthenia gravis (Q34142620) (← links)
- Three types of striational antibodies in myasthenia gravis (Q35116345) (← links)
- Headache Associated with Myasthenia Gravis: The Impact of Mild Ocular Symptoms (Q35142400) (← links)
- Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study (Q35597615) (← links)
- Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study (Q35629867) (← links)
- Response to treatment of myasthenia gravis according to clinical subtype (Q36195346) (← links)
- Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study (Q37681359) (← links)
- Overlooked non-motor symptoms in myasthenia gravis (Q38061891) (← links)
- Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature (Q38245348) (← links)
- Early Aggressive Treatment Strategy against Myasthenia Gravis (Q38479232) (← links)
- Two-year treatment with cyclosporine microemulsion for responder myasthenia gravis patients (Q38482510) (← links)
- Candesartan prevents angiotensin II-induced facilitation of hypoxic neuronal damage through PKCdelta inhibition (Q42477482) (← links)
- Overexpression of alpha7 nicotinic acetylcholine receptor prevents G1-arrest and DNA fragmentation in PC12 cells after hypoxia (Q42522409) (← links)
- Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools (Q42656803) (← links)
- Factors associated with response to calcineurin inhibitors in myasthenia gravis (Q43264720) (← links)
- Autoimmune targets of heart and skeletal muscles in myasthenia gravis (Q43276885) (← links)
- The effect of combined therapy with immunoadsorption and high-dose intravenous methylprednisolone on myasthenia gravis (Q44108531) (← links)
- Over-expression of alpha7 nicotinic acetylcholine receptor induces sustained ERK phosphorylation and N-cadherin expression in PC12 cells (Q44189415) (← links)
- Hypoxic condition interferes with phosphorylation of Akt at Thr(308) in cultured rat pheochromocytoma-12 cells (Q44193497) (← links)
- Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells (Q44291781) (← links)
- Interleukin-2 production by peripheral blood mononuclear cells from patients with myasthenia gravis (Q44368728) (← links)
- Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis (Q44411888) (← links)
- Hypothyroid myopathy caused by interferon-alpha therapy for chronic hepatitis C (Q44800797) (← links)
- Ross syndrome associated with cytomegalovirus infection (Q44885175) (← links)
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study (Q45070916) (← links)
- Efficacy of low-dose FK506 in the treatment of Myasthenia gravis--a randomized pilot study (Q46495927) (← links)
- Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis (Q46540318) (← links)
- Health-related quality-of-life and treatment targets in myasthenia gravis (Q48085548) (← links)
- The MG-QOL15 Japanese version: validation and associations with clinical factors (Q48414932) (← links)
- Rationale for the clinical guidelines for myasthenia gravis in Japan (Q48521116) (← links)
- Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan (Q49629485) (← links)
- Striatocapsular infarction caused by middle cerebral artery dissection. (Q53631601) (← links)
- [Japan MG Registry Study: A Sophisti- cated Multi-center Study of Myasthe- nia Gravis A sophisticated multi-center Study of Myasthenia Gravis]. (Q54412068) (← links)
- Clinical and immunological differences between early and late-onset myasthenia gravis in Japan (Q54633088) (← links)
- Oral corticosteroid therapy and present disease status in myasthenia gravis (Q58047315) (← links)
- Is Surgical Intervention Safe and Effective in the Treatment of Myasthenic Blepharoptosis? A Multicenter Survey in Japan (Q58047406) (← links)
- Topical naphazoline in the treatment of myasthenic blepharoptosis (Q58047503) (← links)
- Classification of Myasthenia Gravis Based on Autoantibody Status (Q58047550) (← links)
- Long-term safety and efficacy of eculizumab in generalized myasthenia gravis (Q66724825) (← links)